F R Spinelli
Overview
Explore the profile of F R Spinelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garufi C, Garufi C, Mancuso S, Mancuso S, Ceccarelli F, Ceccarelli F, et al.
Reumatismo
. 2024 Nov;
77(1).
PMID: 39498784
Objective: Patients Acceptable Symptom State (PASS) is a single dichotomized question assessing health satisfaction. We aimed to investigate PASS achievement within 4 weeks of treatment with Janus kinase (JAK) inhibitors...
2.
Molteni E, Pirone C, Ceccarelli F, Castellani C, Alessandri C, Di Franco M, et al.
Reumatismo
. 2024 Jun;
76(2).
PMID: 38916170
Objective: Data from trials demonstrated that abatacept (ABA) has a good safety and efficacy profile in treating rheumatoid arthritis. We have studied the retention rate of ABA in a real-life...
3.
Iacovantuono M, Ferrigno S, Conigliaro P, Triggianese P, DAntonio A, Spinelli F, et al.
Reumatismo
. 2024 Mar;
76(1).
PMID: 38523584
Objective: A monocentric cross-sectional study recruiting rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients residing in the Lazio region, Italy, to assess factors related to diagnostic delay and treatment accessibility....
4.
Spinelli F, Conti F, Caporali R, Iannone F, Cacciapaglia F, Steering Committee Of The Italian Society Of Rheumatology O
Reumatismo
. 2023 Dec;
75(4).
PMID: 38115771
Following the restrictions on the reimbursability of Janus kinase inhibitors introduced by the Italian Medicines Agency, the Italian Society of Rheumatology has drafted this document to shed light on the...
5.
Vomero M, Caliste M, Barbati C, Speziali M, Celia A, Ucci F, et al.
Front Pharmacol
. 2022 Mar;
13:852802.
PMID: 35308233
The pathway of Janus tyrosine kinases (JAKs) has a central role in the pathogenesis of Rheumatoid Arthritis (RA) by regulating multiple immune functions and cytokine production. The JAK inhibitor tofacitinib...
6.
Lande R, Palazzo R, Gestermann N, Jandus C, Falchi M, Spadaro F, et al.
Sci Rep
. 2020 Apr;
10(1):5851.
PMID: 32245990
LL37 exerts a dual pathogenic role in psoriasis. Bound to self-DNA/RNA, LL37 licenses autoreactivity by stimulating plasmacytoid dendritic cells-(pDCs)-Type I interferon (IFN-I) and acts as autoantigen for pathogenic Th17-cells. In...
7.
Bosello S, Chimenti M, Conigliaro P, Iannuccelli C, Gremese E, Spinelli F, et al.
Reumatismo
. 2020 Jan;
71(4):173-176.
PMID: 31995955
Not available.
8.
Barbati C, Stefanini L, Colasanti T, Cipriano E, Celia A, Gabriele G, et al.
Arthritis Res Ther
. 2019 Jul;
21(1):161.
PMID: 31262358
Background: Thrombocytopenia is a manifestation associated with primary antiphospholipid syndrome (PAPS), and many studies have stressed the leading role played by platelets in the pathogenesis of antiphospholipid syndrome (APS). Platelets...
9.
Novelli L, Barbati C, Ceccarelli F, Perricone C, Spinelli F, Alessandri C, et al.
Lupus
. 2019 Mar;
28(5):621-628.
PMID: 30907297
Background: Adhesion molecule CD44 contributes to T cell migration into target organs. A higher expression of CD44v3 and v6 isoforms has been identified on T cells from systemic lupus erythematosus...
10.
Ceccarelli F, Perricone C, Cipriano E, Massaro L, Natalucci F, Spinelli F, et al.
Lupus
. 2019 Feb;
28(3):383-388.
PMID: 30744521
Specific indices are not available to evaluate systemic lupus erythematosus (SLE) joint involvement; indeed, the application of indices validated for rheumatoid arthritis has been suggested. We evaluated the usefulness of...